Oncotelic Therapeutics Inc (OTLC)

$0.07 0.00 (-5.07%)
Market Cap 34.17M
Revenue (ttm) 0.00
Net Income (ttm) -4.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.72
Volume 54,848
Avg Vol 159,750
Day's Range N/A - N/A
Shares Out 442.60M
Stochastic %K 66%
Beta -0.76
Analysts Strong Buy
Price Target $4.00

Company Profile

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications. It develops antisense and small molecule injectable drugs for the treatment of cancer. The company is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatme...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 635 7000
Fax: 650 635 7001
Address:
29397 Agoura Road, Suite 107, Agoura Hills, United States
ckruel
ckruel Jan. 29 at 11:44 PM
$OTLC On January 23, 2026, Oncotelic Therapeutics secured $398,333 in convertible debt from Mast Hill Fund, issuing a one-year, 10% secured note convertible at $0.07 per share, together with 1,422,613 warrants at $0.15, and restricted the use of proceeds to working capital. The agreement, backed by most company assets and paired with registration rights for the conversion shares and warrants, underscores a leverage-heavy financing that could dilute equity while bolstering near-term liquidity for ongoing oncology programs.
0 · Reply
Ichigodoran
Ichigodoran Jan. 29 at 7:39 PM
$OTLC Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
0 · Reply
Ichigodoran
Ichigodoran Jan. 29 at 2:26 PM
$OTLC https://stockscan.io/stocks/OTLC
0 · Reply
Dingo2
Dingo2 Jan. 29 at 12:21 PM
$OTLC I would be quite happy with this scenario LOL
0 · Reply
Ichigodoran
Ichigodoran Jan. 27 at 4:10 PM
$OTLC Watch this - Oncotelic Therapeutics: Advances in Sapu003 Intravenous Cancer Therapy https://www.youtube.com/watch?v=dbBS0iH3zfk
0 · Reply
Ichigodoran
Ichigodoran Jan. 27 at 1:52 PM
$OTLC Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine https://finance.yahoo.com/news/oncotelic-sapu-nano-announce-deciparticletm-150000503.html
0 · Reply
ckruel
ckruel Jan. 27 at 1:20 AM
$OTLC • Oncotelic amended stock-based milestone agreements, lowering the first market-cap target to $45 million. • The change aims to support financing initiatives and an eventual uplisting, strengthening Oncotelic’s market positioning. Maybe getting close to markup time…….
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 7:10 PM
$OTLC Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus AGOURA HILLS, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today opened access to PDAOAI, its proprietary evidence-interrogation platform designed to extract biologically meaningful signals from large, complex biomedical datasets without training bespoke large language models (LLMs) on proprietary data. The Company is also providing researchers access to a TGF-β literature corpus comprising all known publications for TGF-β- more than 125,000 PubMed abstracts- through a dedicated Discord research channel. https://www.stockwatch.com/News/Item/U-z9615845-U!OTLC-20251222/U/OTLC
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 5:59 PM
$OTLC
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 2:29 PM
$OTLC Must Read! Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer https://finance.yahoo.com/news/oncotelic-therapeutics-brush-key-foundation-150000335.html
0 · Reply
Latest News on OTLC
No data available.
ckruel
ckruel Jan. 29 at 11:44 PM
$OTLC On January 23, 2026, Oncotelic Therapeutics secured $398,333 in convertible debt from Mast Hill Fund, issuing a one-year, 10% secured note convertible at $0.07 per share, together with 1,422,613 warrants at $0.15, and restricted the use of proceeds to working capital. The agreement, backed by most company assets and paired with registration rights for the conversion shares and warrants, underscores a leverage-heavy financing that could dilute equity while bolstering near-term liquidity for ongoing oncology programs.
0 · Reply
Ichigodoran
Ichigodoran Jan. 29 at 7:39 PM
$OTLC Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
0 · Reply
Ichigodoran
Ichigodoran Jan. 29 at 2:26 PM
$OTLC https://stockscan.io/stocks/OTLC
0 · Reply
Dingo2
Dingo2 Jan. 29 at 12:21 PM
$OTLC I would be quite happy with this scenario LOL
0 · Reply
Ichigodoran
Ichigodoran Jan. 27 at 4:10 PM
$OTLC Watch this - Oncotelic Therapeutics: Advances in Sapu003 Intravenous Cancer Therapy https://www.youtube.com/watch?v=dbBS0iH3zfk
0 · Reply
Ichigodoran
Ichigodoran Jan. 27 at 1:52 PM
$OTLC Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine https://finance.yahoo.com/news/oncotelic-sapu-nano-announce-deciparticletm-150000503.html
0 · Reply
ckruel
ckruel Jan. 27 at 1:20 AM
$OTLC • Oncotelic amended stock-based milestone agreements, lowering the first market-cap target to $45 million. • The change aims to support financing initiatives and an eventual uplisting, strengthening Oncotelic’s market positioning. Maybe getting close to markup time…….
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 7:10 PM
$OTLC Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus AGOURA HILLS, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today opened access to PDAOAI, its proprietary evidence-interrogation platform designed to extract biologically meaningful signals from large, complex biomedical datasets without training bespoke large language models (LLMs) on proprietary data. The Company is also providing researchers access to a TGF-β literature corpus comprising all known publications for TGF-β- more than 125,000 PubMed abstracts- through a dedicated Discord research channel. https://www.stockwatch.com/News/Item/U-z9615845-U!OTLC-20251222/U/OTLC
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 5:59 PM
$OTLC
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 2:29 PM
$OTLC Must Read! Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer https://finance.yahoo.com/news/oncotelic-therapeutics-brush-key-foundation-150000335.html
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 2:15 PM
$OTLC - Recent Impact News :
0 · Reply
Thebullrun
Thebullrun Jan. 23 at 2:13 PM
$OTLC
0 · Reply
Ichigodoran
Ichigodoran Jan. 23 at 2:13 PM
$OTLC -
0 · Reply
SmallCapGrowth
SmallCapGrowth Jan. 22 at 6:29 PM
$OTLC Oncotelic Therapeutics Details - MOMO'S BREAKOUT BOARD https://investorshangout.com/post/view?id=6812277
0 · Reply
SmallCapGrowth
SmallCapGrowth Jan. 22 at 3:48 PM
MOMO'S BREAKOUT BOARD : $OTLC Oncotelic Therapeutics Details PDA... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177205171 via @Investors_Hub
0 · Reply
JN14
JN14 Jan. 21 at 3:26 PM
$OTLC
0 · Reply
Ichigodoran
Ichigodoran Jan. 21 at 2:25 PM
$OTLC Recent News : Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer https://finance.yahoo.com/news/oncotelic-therapeutics-brush-key-foundation-150000335.html
0 · Reply
Ichigodoran
Ichigodoran Jan. 21 at 2:02 PM
$OTLC Forecast https://stockscan.io/stocks/OTLC
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 21 at 12:42 PM
$OTLC Great piece that accurately captures OTLC's current position. So if you want to refresh your understanding of OTLC or learn about OTLC for the first time, this is essential reading. https://everyticker.com/quote/OTLC/analysis/the-700-million-question-can-oncotelic-s-joint-venture-bridge-its-going-concern-gap-otc-otlc
0 · Reply
Techallure
Techallure Jan. 21 at 1:11 AM
$OTLC New Delhi [India], January 20: Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful day-long symposium brought together eminent voices, leaders, and experts from across India's life sciences and clinical research ecosystem to deliberate on the future of research, innovation, and collaboration in the country. Tomorrow … only a day away
0 · Reply
Techallure
Techallure Jan. 19 at 1:32 AM
$OTLC finally … a bump up arrives
1 · Reply
Thebullrun
Thebullrun Jan. 15 at 11:34 PM
$OTLC News out !!! Great Quality Companies! Check em out. #NYSE, #NASDAQ, #OTCMARKETS #VMAR Vision #Marine #Technologies -Electric boats #VRME VerifyMe®, Inc #OpenWorld #Web3 #AUID authID Inc. #Biometrics #cybersecurity #AMPG Amplitech #5G #CVM Cel-Sci #biotech #Cancer #NMHI Natures Miracle #XRP #VISM Visium Tech #technology #cybersecurity #DBMM Digital Clarity #AI #OTLC Oncotelic Therapeutics #biotech Get some Dilligence here: great source with a global auidence. https://youtube.com/@thebullrunshow?si=Ghp4pGMy74nfRSoS #AI #wallstreet #TheBullRunShow #Youtube #stockstowatch
0 · Reply